Partner Headlines - MDVN

  1. Medivation Announces Fourth Quarter and Year-End 2015 Financial ...

    GuruFocus
  2. Microsoft, GoPro And 8 More Stocks To Watch Over The Weekend

    Benzinga
  3. Medivation to Present at Leerink Partners 5th Annual Global Healthcare ...

    GuruFocus
  4. Journal of Clinical Oncology Publishes Results From the STRIVE ...

    GuruFocus
  5. Weekly Insider Sells: Medivation, JPMorgan Chase, Stryker, Sabre

    GuruFocus
  6. Lancet Oncology Publishes Results From the Phase 2 TERRAIN Trial ...

    GuruFocus
  7. NanoString Technologies Enters Into Collaboration Agreement With ...

    GuruFocus
  8. Medivation to Present at J.P. Morgan Healthcare Conference

    GuruFocus
  9. Medivation Initiates Pivotal Clinical Trial of MDV9300 in Diffuse ...

    GuruFocus
  10. Wild Short Interest Swings For Three Top Biotech Stocks

    Benzinga
  11. Medivation Announces Third Quarter 2015 Financial Results Teleconference ...

    GuruFocus
  12. Medivation Announces Management Changes

    GuruFocus
  13. Medivation Effects a Stock Dividend on Its Common Stock

    GuruFocus
  14. Amgen And Biogen Lead Short Interest Surge In Biotechs

    Benzinga
  15. A Portfolio To Support Cancer Treatments In Time For Prostate ...

    Benzinga
  16. Medivation Announces Participation at Upcoming Investor Conference

    GuruFocus
  17. Benzinga's Top Initiations

    Benzinga
  18. Medivation to Expand Global Oncology Franchise With the Acquisition ...

    GuruFocus
  19. Benzinga's M&A Chatter for Monday August 24, 2015

    Benzinga
  20. Medivation to Expand Global Oncology Franchise With the Acquisition ...

    Benzinga
  21. Benzinga's Top #PreMarket Gainers

    Benzinga
  22. Medivation Voted Three Years in a Row Among Top Workplaces in ...

    GuruFocus
  23. UPDATE: Medivation, Astellas Report Enrollment of First Patients ...

    Benzinga
  24. New Enzalutamide Data in Triple-Negative Breast Cancer Presented ...

    Benzinga
  25. Stocks: A Soft Jump On Jobs Data; WhiteWave, Boeing, NXP Climb

    IBD
  26. Top Drugmaker Profits Mixed

    IBD
  27. Medivation, Jazz Q1 Reports Miss; Regeneron Beats

    IBD
  28. Four Hot Stocks You'll Want To Keep On Your Radar

    IBD
  29. Nasdaq, S&P 500 Hang Tough; Avago, Akorn Big Earnings Winners

    IBD
  30. Medivation Tops Q4 Views On Strong Xtandi Results

    IBD
  31. Stocks Mixed; United Therapeutics Jumps To New High

    IBD
  32. Market Edges Higher, Unfazed By Weak HP Results

    IBD
  33. Market's Resilience Is Noteworthy; More Breakouts Emerge

    IBD
  34. Earnings Scheduled For February 25, 2015

    Benzinga
  35. Stocks Show Small Losses; Merger Talk Lifts Discovery

    IBD
  36. Stocks Quietly Lower; Domino's, Medivation Break Out

    IBD
  37. Wedbush Weighs in on Medivation Following Phase II TERRAIN Study ...

    GuruFocus
  38. Valeant Agrees To Buy Dendreon's Provenge

    IBD
  39. Weekly CEO Sells Highlight: QAD Inc, Orbitz Worldwide Inc, Constellation ...

    GuruFocus
  40. Enzalutamide Phase 2 Terrain Trial Demonstrated Statistically ...

    GuruFocus
  41. J&J Earnings Beat, But Sales, Guidance Miss Estimates

    IBD
  42. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD
  43. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  44. Barclays Analyst Sees Biotech FY15 EPS Growth Outstripping Market

    Benzinga
  45. William Blair's Top BioPharmaceutical Stock Picks for Q1 2015

    GuruFocus
  46. Newly Profitable Medivation Riding High On Drug Sales

    IBD
  47. Chip Stocks, Biotechs Lead Another Nasdaq Rally

    IBD
  48. Major Upgrades And Downgrades In Friday's Market Action

    Benzinga
  49. Medivation Hits High After Q3 Earnings Beat

    IBD
  50. Medivation Hits High After Q3 Earnings Beat

    IBD
  51. Medivation and Astellas Announce Phase 3 Study of Enzalutamide ...

    GuruFocus
  52. J&J Earnings Beat; Olysio Chatter Hits Gilead

    IBD
  53. Consider Medivation for Your Portfolio

    FoxBusiness
  54. Benzinga's Top Downgrades

    Benzinga
  55. Goldman Sachs Downgrades Medivation To Neutral, Shares Drop

    Benzinga
  56. These 3 Biotech Stocks Just Hit New Highs

    Benzinga
  57. Fast Money Halftime Report Final Trade From September 12

    Benzinga
  58. Medivation Eyes Blockbuster As Cancer Drug Gets An OK

    IBD
  59. Stifel Raises Medivation Inc Price Target

    Benzinga
  60. Stocks Hitting 52-Week Highs

    Benzinga
  61. A Few Reasons Why Investors Should Consider Dendreon for Their ...

    GuruFocus
  62. Medivation Cancer Drug Fuels Beat, Swings To Profit

    IBD
  63. Benzinga's Volume Movers

    Benzinga
  64. Medivation Announces Change in Executive Management Team; Dawn ...

    Benzinga
  65. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  66. Aegis Capital Believes Seragon Deal Underscores Value In Medivation

    Benzinga
  67. UPDATE: Stifel Reiterates On Medivation Following Prostate Cancer ...

    Benzinga
  68. Benzinga's Top Upgrades

    Benzinga
  69. US Stock Futures Flat Ahead Of International Trade Data

    Benzinga
  70. UPDATE: Canaccord Genuity Initiates Coverage on Medivation as ...

    Benzinga
  71. Morning Market Movers

    Benzinga
  72. Stocks To Watch For April 1, 2014

    Benzinga
  73. Celegene, Pharmacyclics Lead Biotech Short Interest Trend (CELG, ...

    Benzinga
  74. UPDATE: Astellas Announces Marketing Approval in Japan for XTANDI® ...

    Benzinga
  75. BioMarin, Medivation Buck Biotech Short Interest Trend (BIIB, ...

    Benzinga
  76. Market Wrap For February 28: Markets Unable To Hold On To Gains

    Benzinga
  77. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE ...

    Benzinga
  78. Benzinga's Top #PreMarket Losers

    Benzinga
  79. 2 Deaths, 25% Plunge -- And Still A Big Upside

    YCharts
  80. Mid-Afternoon Market Update: Fed Will Continue the Taper in February

    Benzinga
  81. Mid-Day Market Update: Yahoo! Slips After Q4 Results; RF Micro ...

    Benzinga
  82. New Year Short Interest Swings In Biotech (BIIB, BMRN, MDVN)

    Benzinga
  83. Mid-Morning Market Update: Markets Open Lower; Dow Chemical Posts ...

    Benzinga
  84. Stocks Hitting 52-Week Highs

    Benzinga
  85. Benzinga's Top #PreMarket Gainers

    Benzinga
  86. Medivation and Astellas Announce Final Results From the Phase ...

    Benzinga
  87. UPDATE: Aegis Capital Reiterates on Medivation Following In-Line ...

    Benzinga
  88. Medivation, Astellas Announce Phase 3 PREVAIL Trial of Enzalutamide ...

    Benzinga
  89. Uh Oh: Is This Cancer Highflyer In Your Account?

    YCharts
  90. Worse-Than-Expected Xtandi Sales Hitting Shares of Medivation; ...

    Benzinga
  91. Medivation Elects Kathryn Falberg to Board of Directors

    Benzinga
  92. Medivation Bulls Load Up on Call Options

    SchaeffersResearch
  93. Aegis Capital Corp. Reiterates Buy Rating, $100 PT on Medivation

    Benzinga
  94. Medivation, Inc. (MDVN) President and CEO David Hung sells 1 ...

    GuruFocus
  95. Benzinga's Top Initiations

    Benzinga
  96. Celgene, Regeneron Pharmaceutical Lead Biomed Group

    IBD
  97. Medivation Inc. (MDVN) Chief Business Officer and CFO Clarence ...

    GuruFocus
  98. UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Medivation

    Benzinga
  99. Medivation Effects 2-for-1 Stock Split

    Benzinga
  100. Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)

    Benzinga
Trading Center